Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

Immunologic Research

Volumn 51, Issue 1, 2011, Pages 26-38

  Basu, Sreemanti ^a,b   Dittel, Bonnie N ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Autoimmunity; Cannabinoid receptor 2; Endocannabinoid; GPCR; Immune suppression; Immune system

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANTIALLERGIC AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; DRONABINOL; JTE 907; RWJ 400065; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE UVEITIS; AUTOIMMUNITY; CELL MIGRATION; CELLULAR IMMUNITY; CYTOKINE RESPONSE; ENTERITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MIGRATION INHIBITION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN ALLERGY; SYSTEMIC SCLEROSIS; TUMOR IMMUNITY; UVEITIS;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION;

EID: 80053571291     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8210-5     Document Type: Article

References (85)

1. M Salzet C Breton T Bisogno V Di Marzo 2000 Comparative biology of the endocannabinoid system possible role in the immune response Eur J Biochem 67 4917 4927 (Pubitemid 30641288)
2. EV Berdyshev 2000 Cannabinoid receptors and the regulation of immune response Chem Phys Lipids 108 169 190 11106790 10.1016/S0009-3084(00)00195-X 1:CAS:528:DC%2BD3cXosFeqtLs%3D
3. WB O'Shaughnessy 1839 On the preparations of the Indian hemp, or Gunjah (Cannabis Indica); their effects on the animal system in health, and their utility in the treatment of tetnus and other convulsive diseases Trans Med Phy Soc Bengal 71 421 426
4. Y Gaoni R Mechoulam 1964 Isolation, structure, and partial synthesis of an active constituent of Hashish J Am Chem Soc 86 1646 1647 10.1021/ja01062a046 1:CAS:528:DyaF2cXkt1GhtLs%3D
5. LA Matsuda SJ Lolait MJ Brownstein AC Young TI Bonner 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561 564 2165569 10.1038/346561a0 1:CAS:528:DyaK3cXls1Ghu7w%3D (Pubitemid 20238806)
6. S Munro KL Thomas M Abu-Shaar 1993 Molecular characterization of a peripheral receptor for cannabinoids Nature 365 61 65 7689702 10.1038/365061a0 1:CAS:528:DyaK3sXmsVWiurk%3D (Pubitemid 23305569)
7. C Gerard C Mollereau G Vassart M Parmentier 1990 Nucleotide sequence of a human cannabinoid receptor cDNA Nucleic Acids Res 18 7142 2263478 10.1093/nar/18.23.7142 1:CAS:528:DyaK3MXisVWlt7k%3D
8. M Bouaboula M Rinaldi P Carayon C Carillon B Delpech D Shire G Le Fur P Casellas 1993 Cannabinoid-receptor expression in human leukocytes Eur J Biochem 214 173 180 8508790 10.1111/j.1432-1033.1993.tb17910.x 1:CAS:528: DyaK3sXks1aru74%3D (Pubitemid 23168532)
9. S Galiegue S Mary J Marchand D Dussossoy D Carriere P Carayon M Bouaboula D Shire G Le Fur P Casellas 1995 Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur J Biochem 232 54 61 7556170 10.1111/j.1432-1033.1995.tb20780.x 1:CAS:528:DyaK2MXnvVKksL8%3D
10. WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffin D Gibson A Mandelbaum A Etinger R Mechoulam 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946 1949 1470919 10.1126/science.1470919 1:CAS:528:DyaK3sXpvVKntg%3D%3D (Pubitemid 23026736)
11. R Mechoulam S Ben-Shabat L Hanus M Ligumsky NE Kaminski AR Schatz A Gopher S Almog BR Martin DR Compton, et al. 1995 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 83 90 7605349 10.1016/0006-2952(95)00109-D 1:CAS:528:DyaK2MXmsl2ks7Y%3D
12. T Sugiura S Kondo A Sukagawa S Nakane A Shinoda K Itoh A Yamashita K Waku 1995 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 89 97 7575630 10.1006/bbrc.1995.2437 1:CAS:528:DyaK2MXosVyqtLk%3D
13. L De Petrocellis MG Cascio V Di Marzo 2004 The endocannabinoid system: a general view and latest additions Br J Pharmacol 141 765 774 14744801 10.1038/sj.bjp.0705666 (Pubitemid 38446177)
14. L Hanus S Abu-Lafi E Fride A Breuer Z Vogel DE Shalev I Kustanovich R Mechoulam 2001 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc Natl Acad Sci USA 98 3662 3665 11259648 10.1073/pnas.061029898 1:CAS:528:DC%2BD3MXis1KitbY%3D (Pubitemid 32249827)
15. SM Huang T Bisogno M Trevisani A Al-Hayani L De Petrocellis F Fezza M Tognetto TJ Petros JF Krey CJ Chu JD Miller SN Davies JM Geppetti P Walker V Di Marzo 2004 An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc Natl Acad Sci USA 99 8400 8405 10.1073/pnas.122196999 (Pubitemid 34651064)
16. AC Porter JM Sauer MD Knierman GW Becker MJ Berna J Bao GG Nomikos P Carter FP Bymaster AB Leese CC Felder 2002 Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 1020 1024 12023533 10.1124/jpet.301.3.1020 1:CAS:528:DC%2BD38XktlGjsLc%3D (Pubitemid 34595094)
17. D Piomelli 2003 The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 873 884 14595399 10.1038/nrn1247 1:CAS:528:DC%2BD3sXosFOktrY%3D (Pubitemid 37351427)
18. V Di Marzo 2011 Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight Nat Neurosci 14 9 15 21187849 10.1038/nn.2720 1:CAS:528:DC%2BC3cXhs1WkurnP
19. M Glass JK Northup 1999 Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors Mol Pharmacol 56 1362 1369 10570066 1:CAS:528:DyaK1MXns1yhurg%3D
20. G Griffin Q Tao ME Abood 2002 Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor J Pharmacol Exp Ther 292 886 894
21. D Shire B Calandra M Rinaldi-Carmona D Oustric B Pessegue O Bonnin-Cabanne G Le Fur D Caput P Ferrara 1996 Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor Biochim Biophys Acta 1307 132 136 8679694
22. RG Pertwee 1999 Pharmacology of cannabinoid receptor ligands Curr Med Chem 6 635 664 10469884 1:CAS:528:DyaK1MXltlKkurg%3D (Pubitemid 29399497)
23. T Sugiura K Waku 2002 Cannabinoid receptors and their endogenous ligands J Biochem 132 7 12 12097154 1:CAS:528:DC%2BD38XmslCitbs%3D (Pubitemid 34832264)
24. NE Kaminski ME Abood FK Kessler BR Martin AR Schatz 1992 Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Mol Pharmacol 42 736 742 1279376 1:CAS:528:DyaK3sXjt1ynsA%3D%3D (Pubitemid 23021475)
25. NE Buckley KL McCoy E Mezey T Bonner A Zimmer CC Felder M Glass 2000 Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor Eur J Pharmacol 396 141 149 10822068 10.1016/S0014-2999(00) 00211-9 1:CAS:528:DC%2BD3cXjsVGntro%3D (Pubitemid 30265571)
26. NE Buckley 2008 The peripheral cannabinoid receptor knockout mice: an update Br J Pharmacol 153 309 318 17965741 10.1038/sj.bjp.0707527 1:CAS:528:DC%2BD1cXovFClug%3D%3D
27. TW Klein H Friedman S Specter 1998 Marijuana, immunity and infection J Neuroimmunol 83 102 115 9610678 10.1016/S0165-5728(97)00226-9 1:CAS:528:DyaK1cXitlSru7w%3D (Pubitemid 28280956)
28. TW Klein 2005 Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5 400 411 15864274 10.1038/nri1602 1:CAS:528: DC%2BD2MXjs1Okurg%3D (Pubitemid 40685989)
29. P Carayon J Marchand D Dussossoy JM Derocq O Jbilo A Bord M Bouaboula S Galiegue P Mondiere G Penarier GL Fur T Defrance P Casellas 1998 Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation Blood 92 3605 3615 9808554 1:CAS:528:DyaK1cXnsVKlsb8%3D (Pubitemid 28525186)
30. SJ Carlisle F Marciano-Cabral A Staab C Ludwick GA Cabral 2002 Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation Int Immunopharmacol 2 69 82 11789671 10.1016/S1567-5769(01)00147-3 1:CAS:528:DC%2BD38Xjt1yltQ%3D%3D (Pubitemid 33086805)
31. S Mukhopadhyay S Das EA Williams D Moore JD Jones DS Zahm MM Ndengele AJ Lechner AC Howlett 2006 Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages J Neuroimmunol 181 82 92 17045344 10.1016/j.jneuroim.2006.08.002 1:CAS:528:DC%2BD28Xht1Krs7fM (Pubitemid 44827292)
32. K Maresz G Pryce ED Ponomarev G Marsicano JL Croxford LP Shriver C Ledent Y Cheng EJ Carrie MK Mann G Giovannoni RG Pertwee T Yamamura NE Buckley CJ Hillard B Lutz D Baker BN Dittel 2007 Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on autoreactive T cells Nat Med 13 492 497 17401376 10.1038/nm1561 1:CAS:528:DC%2BD2sXjvVaqur8%3D (Pubitemid 46559830)
33. MA Jorda SE Verbakel PJ Valk YV Vankan-Berkhoudt M Maccarrone A Finazzi-Agro B Lowenberg R Delwel 2002 Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol Blood 99 2786 2793 11929767 10.1182/blood.V99.8.2786 1:CAS:528:DC%2BD38XivVyqu70%3D (Pubitemid 34525366)
34. L Walter A Franklin A Witting C Wade KunosG XieY K Mackie N Stella 2003 Nonpsychotropic cannabinoid receptors regulate microglial cell migration J Neurosci 23 1398 1405 12598628 1:CAS:528:DC%2BD3sXit1antb0%3D (Pubitemid 36258918)
35. S Kishimoto M Gokoh S Oka M Muramatsu T Kajiwara K Waku T Sugiura 2003 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism J Biol Chem 278 24469 24475 12711605 10.1074/jbc.M301359200 1:CAS:528:DC%2BD3sXltVSmtb4%3D (Pubitemid 37548598)
36. J Maestroni 2004 The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein Faseb J 18 1914 1916 15385435 1:CAS:528:DC%2BD2cXhtVKktLvM
37. S Oka S Ikeda S Kishimoto M Gokoh S Yanagimoto K Waku T Sugiura 2004 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils J Leukoc Biol 76 1002 1009 15316028 10.1189/jlb.0404252 1:CAS:528:DC%2BD2cXpvVCisr8%3D (Pubitemid 39458711)
38. R Kurihara T Tohyama S Matsusaka H Naruse E Kinoshita T Tsujioka Y Katsumata H Yamamura 2006 Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils J Biol Chem 281 12908 12918 16513651 10.1074/jbc.M510871200 1:CAS:528: DC%2BD28XjvFKktbk%3D (Pubitemid 43855384)
39. S Kishimoto M Muramatsu M Gokoh S Oka K Waku T Sugiura 2005 Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells J Biochem 137 217 223 15749836 10.1093/jb/mvi021 1:CAS:528:DC%2BD2MXjs1eqsLo%3D
40. T Tanikawa K Kurohane Y Imai 2007 Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice Microbiol Immunol 51 1013 1019 17951991 1:CAS:528:DC%2BD2sXhtlyhtLfI (Pubitemid 47628647)
41. M Rinaldi-Carmona F Barth J Millan JM Derocq P Casellas C Congy D Oustric M Sarran M Bouaboula B Calandra M Portier D Shire JC Breliere GL Le Fur 1998 SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J Pharmacol Exp Ther 284 644 650 9454810 1:CAS:528:DyaK1cXhtFWkt78%3D (Pubitemid 28086654)
42. ES Raborn F Marciano-Cabral NE Buckley BR Martin GA Cabral 2008 The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor J Neuroimmune Pharmacol 3 117 129 18247131 10.1007/s11481-007-9077-z
43. F Montecucco F Burger F Mach S Steffens 2008 CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways Am J Physiol Heart Circ Physiol 294 H1145 H1155 18178718 10.1152/ajpheart.01328.2007 1:CAS:528:DC%2BD1cXjsFymsLY%3D (Pubitemid 351468709)
44. EA Romero-Sandoval R Horvath RP Landry JA DeLeo 2009 Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation Mol Pain 5 25 39 19476641 10.1186/1744-8069-5-25
45. S Ghosh A Preet JE Groopman RK Ganju 2006 Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes Mol Immunol 43 2169 2179 16503355 10.1016/j.molimm.2006.01.005 1:CAS:528:DC%2BD28XlsFCns7c%3D (Pubitemid 43831198)
46. JM Derocq M Segui J Marchand G Le Fur P Casellas 1995 Cannabinoids enhance human B-cell growth at low nanomolar concentrations FEBS Lett 369 177 182 7544292 10.1016/0014-5793(95)00746-V 1:CAS:528:DyaK2MXnslyhsr8%3D
47. EJ Carrier CS Kearn AJ Barkmeier NM Breese W Yang K Nithipatikom SL Pfister WB Campbell CJ Hillard 2004 Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism Mol Pharmacol 65 999 1007 15044630 10.1124/mol.65.4.999 1:CAS:528:DC%2BD2cXivFaltb0%3D (Pubitemid 38420506)
48. Y Do RJ McKallip M Nagarkatti PS Nagarkatti 2004 Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation J Immunol 173 2373 2382 15294950 1:CAS:528:DC%2BD2cXmt1Ols7c%3D (Pubitemid 39063093)
49. C Lombard M Nagarkatti P Nagarkatti 2007 CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents Clin Immunol 122 259 270 17185040 10.1016/j.clim.2006.11.002 1:CAS:528:DC%2BD2sXhs1Chu7k%3D (Pubitemid 46216921)
50. F Correa F Docagne L Mestre D Clemente M Hernangomez F Loria C Guaza 2009 A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells Biochem Pharmacol 77 86 100 18848818 10.1016/j.bcp.2008.09.014 1:CAS:528:DC%2BD1cXhsVGhurfJ
51. F Correa M Hernangomez L Mestre F Loria A Spagnolo F Docagne V Di Marzo C Guaza 2010 Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB Glia 58 135 147 19565660 10.1002/glia.20907
52. M Agudelo C Newton R Widen T Sherwood L Nong H Friedman TW Klein 2008 Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes J Neuroimmune Pharmacol 3 35 42 18247126 10.1007/s11481-007-9088-9
53. S Chuchawankul M Shima NE Buckley CB Hartmann KL McCoy 2004 Role of cannabinoid receptors in inhibiting macrophage costimulatory activity Int Immunopharmacol 4 265 278 14996418 10.1016/j.intimp.2003.12.011 1:CAS:528:DC%2BD2cXhslSkt78%3D (Pubitemid 38296355)
54. C Borner M Smida V Hollt B Schraven J Kraus 2009 Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling J Biol Chem 284 35450 35460 19858202 10.1074/jbc.M109.006338
55. K Gustafsson B Christensson B Sander J Flygare 2006 Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55, 212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma Mol Pharmacol 70 1612 1620 16936228 10.1124/mol.106.025981 1:CAS:528: DC%2BD28XhtFygsbnF
56. S Jiang M Alberich-Jorda R Zagozdzon K Parmar Y Fu P Mauch N Banu A Makriyannis DG Tenen S Avraham JE Groopman HK Avraham 2011 Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization Blood 117 827 838 21063029 10.1182/blood-2010-01-265082 1:CAS:528:DC%2BC3MXhslKks78%3D
57. JL Shoemaker MB Ruckle PR Mayeux L Prather 2005 Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors J Pharmacol Exp Ther 315 828 838 16081674 10.1124/jpet.105.089474 1:CAS:528: DC%2BD2MXhtFyhtrzO (Pubitemid 41509039)
58. M Bouaboula N Desnoyer P Carayon T Combes P Casellas 1999 Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation Mol Pharmacol 55 473 480 10051530 1:CAS:528:DyaK1MXhslWjur4%3D (Pubitemid 29128103)
59. D Ziring B Wei P Velazquez M Schrage NE Buckley J Braun 2006 Formation of B and T cell subsets require the cannabinoid receptor CB2 Immunogenetics 58 714 725 16924491 10.1007/s00251-006-0138-x 1:CAS:528:DC%2BD28XptVGqtbg%3D (Pubitemid 44343145)
60. JP Pereira J An Y Xu Y Huang JG Cyster 2009 Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids Nat Immunol 10 403 411 19252491 10.1038/ni.1710 1:CAS:528:DC%2BD1MXisVOruro%3D
61. TW Klein CA Newton N Nakachi H Friedman 2000 Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection J Immunol 164 6461 6466 10843702 1:CAS:528:DC%2BD3cXktFWltLY%3D (Pubitemid 30408829)
62. CA Newton TW Klein H Friedman 1994 Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection Infect Immunol 62 4015 4020 1:CAS:528:DyaK2cXmt1WksL4%3D (Pubitemid 24264350)
63. B Csoka ZH Nemeth P Mukhopadhyay Z Spolarics M Rajesh S Federici EA Deitch S Batkai P Pacher G Hasko 2009 CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis PLoS One 4 e6409 19641602 10.1371/journal.pone.0006409
64. J Tschop KR Kasten R Nogueiras HS Goetzman CM Cave LG England J Dattilo AB Lentsch MH Tschop CC Caldwell 2009 The cannabinoid receptor 2 is critical for the host response to sepsis J Immunol 183 499 505 19525393 10.4049/jimmunol. 0900203
65. LX Zhu S Sharma M Stolina B Gardner MD Roth DP Tashkin SM Dubinett 2000 Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway J Immunol 165 373 380 10861074 1:CAS:528:DC%2BD3cXksVKltrg%3D (Pubitemid 30429529)
66. M Vocanson A Hennino A Rozieres G Poyet JF Nicolas 2009 Effector and regulatory mechanisms in allergic contact dermatitis Allergy 64 1699 1714 19839974 10.1111/j.1398-9995.2009.02082.x 1:CAS:528:DC%2BD1MXhsFOlsrvM
67. M Karsak E Gaffal R Date L Wang-Eckhardt J Rehnelt S Petrosino K Starowicz R Steuder E Schlicker B Cravatt R Mechoulam R Buettner S Werner V Di Marzo T Tuting A Zimmer 2007 Attenuation of allergic contact dermatitis through the endocannabinoid system Science 316 1494 1497 17556587 10.1126/science. 1142265 1:CAS:528:DC%2BD2sXmtFSjtrs%3D (Pubitemid 46906619)
68. Y Ueda N Miyagawa T Matsui T Kaya H Iwamura 2005 Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice Eur J Pharmacol 520 164 171 16153638 10.1016/j.ejphar.2005.08.013 1:CAS:528: DC%2BD2MXhtVKisLjP (Pubitemid 41375825)
69. S Oka J Wakui M Gokoh S Kishimoto T Sugiura 2006 Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2- arachidonoylglycerol Eur J Pharmacol 538 154 162 16647054 10.1016/j.ejphar.2006. 03.021 1:CAS:528:DC%2BD28XkvVygurc%3D
70. CC Bunn CM Black 1999 Systemic sclerosis: an autoantibody mosaic Clin Exp Immunol 117 207 208 10444248 10.1046/j.1365-2249.1999.00990.x 1:STN:280:DyaK1MzntlKiuw%3D%3D (Pubitemid 29343588)
71. SI Nihtyanova CP Denton 2010 Autoantibodies as predictive tools in systemic sclerosis Nat Rev Rheumatol 6 112 116 20125179 10.1038/nrrheum.2009.238 1:CAS:528:DC%2BC3cXhsVSru7s%3D
72. A Servettaz C Goulvestre N Kavian C Nicco P Guilpain C Chereau V Vuiblet L Guillevin L Mouthon B Weill F Batteux 2009 Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse J Immunol 182 5855 5864 19380834 10.4049/jimmunol.0803705 1:CAS:528:DC%2BD1MXkslKhtrc%3D
73. A Servettaz N Kavian C Nicco V Deveaux C Chereau A Wang A Zimmer S Lotersztajn B Weill F Batteux 2010 Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis Am J Pathol 177 187 196 20508030 10.2353/ajpath.2010.090763
74. RR Caspi 2010 A look at autoimmunity and inflammation in the eye J Clin Invest 120 3073 3083 20811163 10.1172/JCI42440 1:CAS:528:DC%2BC3cXhtFertbzE
75. RB Nussenblatt I Gery 1996 Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease J Autoimmun 9 575 585 8933273 10.1006/jaut.1996.0077 1:STN:280:DyaK2s%2Foslaksg%3D%3D (Pubitemid 26370968)
76. H Xu CL Cheng M Chen A Manivannan L Cabay RG Pertwee A Coutts JV Forrester 2007 Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis J Leukoc Biol 82 532 541 17537989 10.1189/jlb.0307159 1:CAS:528:DC%2BD2sXhtValu7rM (Pubitemid 47367143)
77. C Abraham JH Cho 2009 Inflammatory bowel disease N Engl J Med 361 2066 2078 19923578 10.1056/NEJMra0804647 1:CAS:528:DC%2BD1MXhsVequ7bE
78. MA Storr CM Keenan H Zhang KD Patel A Makriyannis KA Sharkey 2009 Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis Inflamm Bowel Dis 15 1678 1685 19408320 10.1002/ibd.20960
79. ES Kimball CR Schneider NH Wallace PJ Hornby 2006 Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium Am J Physiol Gastrointest Liver Physiol 291 G364 G371 16574988 10.1152/ajpgi.00407.2005 1:CAS:528:DC%2BD28XovVWgu74%3D (Pubitemid 44024696)
80. M Sospedra R Martin 2005 Immunology of multiple sclerosis Annu Rev Immunol 23 683 747 15771584 10.1146/annurev.immunol.23.021704.115707 1:CAS:528:DC%2BD2MXktFOju7w%3D (Pubitemid 40563183)
81. L Jean-Gilles S Feng CR Tench V Chapman DA Kendall DA Barrett CS Constantinescu 2009 Plasma endocannabinoid levels in multiple sclerosis J Neurol Sci 287 212 215 19695579 10.1016/j.jns.2009.07.021 1:CAS:528:DC%2BD1MXhtlylsrbJ
82. A Arevalo-Martin JM Vela E Molina-Holgado J Borrell C Guaza 2003 Therapeutic action of cannabinoids in a murine model of multiple sclerosis J Neurosci 23 2511 2516 12684434 1:CAS:528:DC%2BD3sXjtFCnsb4%3D (Pubitemid 36418583)
83. X Ni EB Geller MJ Eppihimer TK Eisenstein MW Adler RF Tuma 2004 Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model Mult Scler 10 158 164 15124761 10.1191/1352458504ms1009oa 1:CAS:528:DC%2BD2cXktlKgt70%3D (Pubitemid 38499908)
84. D Baker G Pryce JL Croxford P Brown RG Pertwee JW Huffman L Layward 2000 Cannabinoids control spasticity and tremor in a multiple sclerosis model Nature 404 84 87 10716447 10.1038/35003583 1:CAS:528:DC%2BD3cXhvVyqsb4%3D (Pubitemid 30143137)
85. G Pryce D Baker 2007 Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors Br J Pharmacol 150 519 525 17220914 10.1038/sj.bjp.0707003 1:CAS:528:DC%2BD2sXhvVeltrk%3D (Pubitemid 46280648)